SCHEMBL4615894

SCHEMBL4615894

Cc1ccc(S(=O)(=O)c2ccc3c(c2)CCCC3)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.65
GAA P10253 1/20 0.57
ALDH1A1 P00352 4/20 0.56
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
THRB P10828 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA7 P43166 1/20 0.53
CA14 Q9ULX7 1/20 0.53
HTR2C P28335 4/20 0.53
HTR2B P41595 4/20 0.53
PNMT P11086 1/20 0.46
LOXL2 Q9Y4K0 2/20 0.46
RAPGEF4 Q8WZA2 1/20 0.46
KDM4E B2RXH2 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1706010 0.84 HTR2C (0.73) ALDH1A1LMNATHRBCA12CA1
SCHEMBL8509022 0.82 CA2 (0.53) DPP4GAAALDH1A1CA12CA1
SCHEMBL10497962 0.80 CA12 (0.51) DPP4GAAALDH1A1LMNASMN1; SMN2
SCHEMBL17361761 0.79 MAOA (0.56) DPP4GAAALDH1A1LMNASMN1; SMN2
SCHEMBL8509309 0.79 CA12 (0.58) DPP4GAAALDH1A1CA12CA1
SCHEMBL10497592 0.78 ALDH1A1 (0.63) GAAALDH1A1L3MBTL1CA12CA1
SCHEMBL9646810 0.77 CA12 (0.56) DPP4GAAALDH1A1CA12CA1
SCHEMBL11948273 0.77 PNMT (0.61) DPP4ALDH1A1LMNASMN1; SMN2THRB
SCHEMBL10497953 0.77 CA12 (0.56) DPP4GAAALDH1A1LMNASMN1; SMN2
SCHEMBL9958040 0.77 STS (0.57) DPP4ALDH1A1LMNASMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 DPP4 1482/4885GAA 4113/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.